市場調査レポート

商品コード

1747534

全身麻酔薬市場：薬剤分子別、投与経路別、エンドユーザー別、地域別

General Anesthesia Drugs Market, By Drug molecule, By Route of Administration, By End User, By Geography

出版日: 2025年05月16日
発行: Coherent Market Insights
ページ情報: 英文 200 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 658,620円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,024,520円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,463,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.36円

全表示
概要
目次

概要

サンプル依頼リストに入れる

全身麻酔薬の市場規模は2025年に53億6,000万米ドルと推定され、2032年には71億米ドルに達すると予測され、2025～2032年までのCAGRは4.1%です。

レポート範囲		レポート詳細
基準年	2024年	2025年の市場規模	53億6,000万米ドル
実績データ	2020～2024年	予測期間	2025～2032年
予測期間：2025～2032年 CAGR：	4.10%	2032年の価値予測	71億米ドル

全身麻酔薬は、全身麻酔に使用される主要な薬剤クラスの一つです。全身麻酔薬は、肺がんや喘息などの呼吸器疾患、先天性心疾患や心筋梗塞などの心臓疾患、痙攣やパーキンソン病などの神経疾患、重度の火傷や外傷性脳損傷など、さまざまな病状に対して投与されますが、これらに限定されるものではありません。全身麻酔は、豊胸手術や鼻の手術といった美容上の理由でも行われます。

市場力学

麻酔薬の研究開発資金の増加は、予測期間中の全身麻酔薬市場の成長を促進すると予想されます。例えば、2021年8月、セントルイスのワシントン大学医学部とミシガン大学の研究者は、一般的な麻酔薬のどちらが患者の回復体験と臨床転帰の改善をもたらすかを明らかにするために、静脈内プロポフォールと吸入麻酔薬を比較するために、Patient-Centered Outcomes Research Instituteから3,300万米ドルの助成金を受け取りました。

製品リコールは、予測期間中の全身麻酔薬市場の成長を制限すると予想されます。例えば、2021年5月、Hospiraは、注射用病院麻酔薬ブピバカインHCLとリドカインHCLの各1ロットを製品の誤表示により回収すると発表しました。

本調査の主な特徴

本レポートでは、全身麻酔薬市場を詳細に分析し、2024年を基準年とした予測期間2025～2032年の市場規模および複合年間成長率（CAGR%）を提供しています。
さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の全身麻酔薬市場における主要企業プロファイルを掲載しています。
このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
この調査レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
利害関係者は、世界の全身麻酔薬市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

企業プロファイル
- Baxter Healthcare
- Reddy's Laboratories
- Novartis International AG
- Hospira
- Maruishi
- Hengrui
- Lunan
- Fresenius Kabi
- Pfizer Inc.
- Hikma Pharmaceuticals
- Sagent Pharmaceuticals
- Teva Pharmaceuticals
- Par Pharmaceutical
- Viatris Inc.
- AbbVie
- Piramal Critical Care
- Aspen Global Incorporated
- B. Braun SE
- Abbott
- Cosmo pharmaceuticals

第9章セクション

参考文献
調査手法

Product Code: CMI524

General Anesthesia Drugs Market size is estimated to be valued at USD 5.36 Bn in 2025 and is expected to reach USD 7.1 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 4.1% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 5.36 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.10%	2032 Value Projection:	USD 7.1 Bn

General anesthetics is one of the major classes of drugs used for general anesthesia. General anesthetics can be administered for a number of medical conditions including but not limited to the following: respiratory problems, such as lung cancer and asthma; cardiac problems, such as congenital heart disease and myocardial infarction; neurological disorders, such as seizures and Parkinson's disease; severe burns and traumatic brain injury. General anesthesia can also be given for cosmetic reasons, such as breast augmentation and nose surgery.

Market Dynamics

Increasing funding for R&D in anesthetic drugs is expected to propel growth of the general anesthesia drugs market over the forecast period. For instance, in August 2021, researchers at Washington University School of Medicine in St. Louis and the University of Michigan received a US$ 33 million grant from the Patient-Centered Outcomes Research Institute to compare intravenous propofol to inhaled anesthetic drugs to determine which of the common anesthetic drugs offers better patient recovery experiences and improved clinical outcomes.

Product recall is expected to limit growth of the general anesthesia drugs market over the forecast period. For instance, in May 2021, Hospira announced to recall one lot each of the injectable hospital anesthetics bupivacaine HCL and lidocaine HCL due to mislabeling of product.

Key features of the study

This report provides in-depth analysis of the general anesthesia drugs market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global general anesthesia drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Baxter International Inc., AstraZeneca, AbbVie Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, and Hospira Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global general anesthesia drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global general anesthesia drugs market

Detailed Segmentation

Global General Anesthesia Drugs Market, By Molecule Type
- Propofol
- Sevoflurane
- Dexmedetomidine
- Desflurane
- Remifentanil
- Midazolam
Global General Anesthesia Drugs Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Baxter Healthcare
- Dr. Reddy's Laboratories
- Fresenius KabiPfizer Inc.
- Hikma Pharmaceuticals
- Sagent Pharmaceuticals
- Teva Pharmaceuticals
- Par Pharmaceutical
- Viatris Inc.
- AbbVie
- Piramal Critical Care
- Aspen Global Incorporated
- B. Braun SE
- Abbott
- COSMO PHARMACEUTICALS
- Hospira Inc.
- Maruishi
- Hengrui
- Lunan

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Molecule
- Market Snippet, By Route of Administration
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Development
Pipeline Analysis
Distribution Channel Analysis
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global General Anesthesia Drug Market , By Drug Molecule, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Desflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Isoflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Propofol
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Etomidate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Methoexital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Hiopentone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Midazolam
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Ketamine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends

5. Global General Anesthesia Drug Market , By Route of Administration, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Intravenous Anesthesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Inhalation Anesthesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends

6. Global General Anesthesia Drug Market , By End User, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

7. Global General Anesthesia Drug Market , By Region, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 -2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 - 2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 - 2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 - 2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 - 2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Drug Molecule, 2020 -2032, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2020 - 2032, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Baxter Healthcare
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Reddy's Laboratories
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Novartis International AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Hospira
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Maruishi
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Hengrui
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Lunan
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Fresenius Kabi
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Hikma Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Sagent Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Teva Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Par Pharmaceutical
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Viatris Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- AbbVie
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Piramal Critical Care
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Aspen Global Incorporated
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- B. Braun SE
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Abbott
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cosmo pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies

9. Section

References
Research Methodology
About us and Sales Contact

全身麻酔薬市場：薬剤分子別、投与経路別、エンドユーザー別、地域別

General Anesthesia Drugs Market, By Drug molecule, By Route of Administration, By End User, By Geography

市場力学

目次

第1章調査目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の全身麻酔薬市場：薬剤分子別、2020～2032年

第5章世界の全身麻酔薬市場：投与経路別、2020～2032年

第6章世界の全身麻酔薬市場：エンドユーザー別、2020～2032年

第7章世界の全身麻酔薬市場：地域別、2020～2032年

第8章競合情勢

第9章セクション

Market Dynamics

Detailed Segmentation

Table of Contents

1. Research Objective and Assumption

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global General Anesthesia Drug Market , By Drug Molecule, 2020 - 2032, (US$ Bn)

5. Global General Anesthesia Drug Market , By Route of Administration, 2020 - 2032, (US$ Bn)

6. Global General Anesthesia Drug Market , By End User, 2020 - 2032, (US$ Bn)

7. Global General Anesthesia Drug Market , By Region, 2020 - 2032, (US$ Bn)

8. Competitive Landscape

9. Section

全身麻酔薬市場：薬剤分子別、投与経路別、エンドユーザー別、地域別

General Anesthesia Drugs Market, By Drug molecule, By Route of Administration, By End User, By Geography

市場力学

目次

第1章 調査目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 世界の全身麻酔薬市場：薬剤分子別、2020～2032年

第5章 世界の全身麻酔薬市場：投与経路別、2020～2032年

第6章 世界の全身麻酔薬市場：エンドユーザー別、2020～2032年

第7章 世界の全身麻酔薬市場：地域別、2020～2032年

第8章 競合情勢

第9章 セクション

Market Dynamics

Detailed Segmentation

Table of Contents

1. Research Objective and Assumption

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global General Anesthesia Drug Market , By Drug Molecule, 2020 - 2032, (US$ Bn)

5. Global General Anesthesia Drug Market , By Route of Administration, 2020 - 2032, (US$ Bn)

6. Global General Anesthesia Drug Market , By End User, 2020 - 2032, (US$ Bn)

7. Global General Anesthesia Drug Market , By Region, 2020 - 2032, (US$ Bn)

8. Competitive Landscape

9. Section

第1章調査目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の全身麻酔薬市場：薬剤分子別、2020～2032年

第5章世界の全身麻酔薬市場：投与経路別、2020～2032年

第6章世界の全身麻酔薬市場：エンドユーザー別、2020～2032年

第7章世界の全身麻酔薬市場：地域別、2020～2032年

第8章競合情勢

第9章セクション